These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study. Bora RP; Prabhakar R Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468 [TBL] [Abstract][Full Text] [Related]
26. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides. Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Menard C; Bastianetto S; Quirion R Front Cell Neurosci; 2013; 7():281. PubMed ID: 24421757 [TBL] [Abstract][Full Text] [Related]
28. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial. Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304 [TBL] [Abstract][Full Text] [Related]
29. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD. Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348 [TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzyme. da Cruz CH; Seabra G J Chem Inf Model; 2014 May; 54(5):1380-90. PubMed ID: 24697863 [TBL] [Abstract][Full Text] [Related]
31. Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-ε4-associated Alzheimer's disease. Delikkaya B; Moriel N; Tong M; Gallucci G; de la Monte SM Alzheimers Dement (Amst); 2019 Dec; 11():392-404. PubMed ID: 31193223 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis. Zhang H; Liu D; Huang H; Zhao Y; Zhou H Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797 [TBL] [Abstract][Full Text] [Related]
34. The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer's disease. Hayrabedyan S; Todorova K; Spinelli M; Barnea ER; Mueller M Oncotarget; 2018 Sep; 9(74):33884-33895. PubMed ID: 30338033 [TBL] [Abstract][Full Text] [Related]
35. Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? Liu Z; Zhu H; Fang GG; Walsh K; Mwamburi M; Wolozin B; Abdul-Hay SO; Ikezu T; Leissring MA; Qiu WQ J Alzheimers Dis; 2012; 29(2):329-40. PubMed ID: 22232014 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review. Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698 [TBL] [Abstract][Full Text] [Related]
37. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs. Martín-Martín Y; Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Pardo-Marqués V; Casarejos MJ; Busto R; Ramírez CM Cells; 2022 Aug; 11(16):. PubMed ID: 36010613 [TBL] [Abstract][Full Text] [Related]
38. Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation. Bulloj A; Leal MC; Surace EI; Zhang X; Xu H; Ledesma MD; Castaño EM; Morelli L Mol Neurodegener; 2008 Dec; 3():22. PubMed ID: 19117523 [TBL] [Abstract][Full Text] [Related]
39. Ubiquitin is a novel substrate for human insulin-degrading enzyme. Ralat LA; Kalas V; Zheng Z; Goldman RD; Sosnick TR; Tang WJ J Mol Biol; 2011 Feb; 406(3):454-66. PubMed ID: 21185309 [TBL] [Abstract][Full Text] [Related]
40. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme. McCord LA; Liang WG; Dowdell E; Kalas V; Hoey RJ; Koide A; Koide S; Tang WJ Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13827-32. PubMed ID: 23922390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]